2012 Q1 Form 10-Q Financial Statement

#000114420412027198 Filed on May 09, 2012

View on sec.gov

Income Statement

Concept 2012 Q1 2011 Q4 2011 Q1
Revenue $3.861M $690.0K $4.128M
YoY Change -6.47% -91.0% 385.65%
Cost Of Revenue $1.320M $400.0K $778.0K
YoY Change 69.67% -90.87%
Gross Profit $2.408M $290.0K $5.222M
YoY Change -53.89% -91.16%
Gross Profit Margin 62.37% 42.03% 126.5%
Selling, General & Admin $1.630M $8.390M $1.990M
YoY Change -18.09% 7.15% 22.84%
% of Gross Profit 67.69% 2893.1% 38.11%
Research & Development $8.847M $760.0K $10.56M
YoY Change -16.25% -88.81% 17.63%
% of Gross Profit 367.4% 262.07% 202.28%
Depreciation & Amortization $930.0K $930.0K $880.0K
YoY Change 5.68% 4.49% 25.71%
% of Gross Profit 38.62% 320.69% 16.85%
Operating Expenses $8.847M $9.150M $10.56M
YoY Change -16.25% -24.57% 17.76%
Operating Profit -$6.065M -$8.860M -$5.038M
YoY Change 20.39% 0.11%
Interest Expense $160.0K -$60.00K -$10.00K
YoY Change -1700.0% -118.75% -105.88%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$5.900M -$8.910M -$5.050M
YoY Change 16.83% 4.45% -36.56%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$5.904M -$8.910M -$5.052M
YoY Change 16.86% 4.45% -36.53%
Net Earnings / Revenue -152.91% -1291.3% -122.38%
Basic Earnings Per Share
Diluted Earnings Per Share -$0.67 -$1.04 -$0.62
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2012 Q1 2011 Q4 2011 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $45.60M $27.00M $50.20M
YoY Change -9.16% -24.79% -27.67%
Cash & Equivalents $45.61M $27.00M $50.23M
Short-Term Investments
Other Short-Term Assets $3.800M
YoY Change
Inventory $263.0K $279.0K $1.100M
Prepaid Expenses $235.0K
Receivables $815.0K $1.374M $6.400M
Other Receivables $3.154M $3.837M $4.500M
Total Short-Term Assets $49.84M $32.49M $62.30M
YoY Change -20.0% -29.83% -14.66%
LONG-TERM ASSETS
Property, Plant & Equipment $17.51M $18.27M $17.70M
YoY Change -1.09% 4.41% 20.41%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.100M $1.000M $1.000M
YoY Change 10.0% 11.11% 25.0%
Total Long-Term Assets $18.63M $19.31M $18.60M
YoY Change 0.15% 4.97% 20.78%
TOTAL ASSETS
Total Short-Term Assets $49.84M $32.49M $62.30M
Total Long-Term Assets $18.63M $19.31M $18.60M
Total Assets $68.46M $51.81M $80.90M
YoY Change -15.37% -19.93% -8.48%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.600M $5.000M $7.500M
YoY Change -38.67% -20.63% 38.89%
Accrued Expenses $2.327M
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $17.72M $18.69M $20.10M
YoY Change -11.82% -1.1% 1.52%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $6.566M $0.00
YoY Change
Other Long-Term Liabilities $5.623M $6.566M $56.10M
YoY Change -89.98% -88.5% -7.12%
Total Long-Term Liabilities $57.20M $59.19M $56.10M
YoY Change 1.96% 3.66% -7.12%
TOTAL LIABILITIES
Total Short-Term Liabilities $17.72M $18.69M $20.10M
Total Long-Term Liabilities $57.20M $59.19M $56.10M
Total Liabilities $74.92M $77.88M $76.20M
YoY Change -1.68% 2.34% -4.99%
SHAREHOLDERS EQUITY
Retained Earnings -$172.0M
YoY Change
Common Stock $145.9M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$6.457M -$26.08M $4.705M
YoY Change
Total Liabilities & Shareholders Equity $68.46M $51.81M $80.90M
YoY Change -15.37% -19.93% -8.48%

Cashflow Statement

Concept 2012 Q1 2011 Q4 2011 Q1
OPERATING ACTIVITIES
Net Income -$5.904M -$8.910M -$5.052M
YoY Change 16.86% 4.45% -36.53%
Depreciation, Depletion And Amortization $930.0K $930.0K $880.0K
YoY Change 5.68% 4.49% 25.71%
Cash From Operating Activities -$6.281M -$6.610M -$3.988M
YoY Change 57.5% -17.68% -55.44%
INVESTING ACTIVITIES
Capital Expenditures $810.0K $710.0K $2.604M
YoY Change -68.89% -31.73% -12.03%
Acquisitions
YoY Change
Other Investing Activities $42.00K -$40.00K $46.00K
YoY Change -8.7% 0.0% -215.0%
Cash From Investing Activities -$852.0K -$750.0K -$2.650M
YoY Change -67.85% -29.91% -11.67%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $25.40M $20.60M
YoY Change 23.3%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $25.57M 20.00K 20.94M
YoY Change 22.15% -94.12%
NET CHANGE
Cash From Operating Activities -$6.281M -6.610M -3.988M
Cash From Investing Activities -$852.0K -750.0K -2.650M
Cash From Financing Activities $25.57M 20.00K 20.94M
Net Change In Cash $18.44M -7.340M 14.30M
YoY Change 28.98% -16.21% -219.65%
FREE CASH FLOW
Cash From Operating Activities -$6.281M -$6.610M -$3.988M
Capital Expenditures $810.0K $710.0K $2.604M
Free Cash Flow -$7.091M -$7.320M -$6.592M
YoY Change 7.57% -19.29% -44.65%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2012Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
91891578 shares
CY2011Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
50227000
CY2011Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2011Q1 us-gaap Stockholders Equity
StockholdersEquity
4705000
CY2011Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2012Q1 us-gaap Liabilities Current
LiabilitiesCurrent
17724000
CY2012Q1 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
8298000
CY2012Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
4858000
CY2012Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
815000
CY2012Q1 us-gaap Assets
Assets
68464000
CY2012Q1 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
3154000
CY2012Q1 us-gaap Defined Benefit Plan Assets For Plan Benefits Noncurrent
DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent
1120000
CY2012Q1 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
49781000
CY2012Q1 us-gaap Inventory Net
InventoryNet
263000
CY2011Q1 us-gaap Pension And Other Postretirement Benefit Contributions
PensionAndOtherPostretirementBenefitContributions
7000
CY2011Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3988000
CY2012Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2012Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
57197000
CY2012Q1 us-gaap Assets Current
AssetsCurrent
49837000
CY2012Q1 us-gaap Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent
PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
1793000
CY2012Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
5623000
CY2012Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
45605000
CY2012Q1 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
4568000
CY2012Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2012Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
68464000
CY2012Q1 us-gaap Stockholders Equity
StockholdersEquity
-6457000
CY2012Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
17507000
CY2012Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2012Q1 us-gaap Liabilities
Liabilities
74921000
CY2010Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
35900000
CY2010Q4 us-gaap Stockholders Equity
StockholdersEquity
-11323000
CY2011Q4 us-gaap Liabilities Current
LiabilitiesCurrent
18693000
CY2011Q4 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
7540000
CY2011Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
6121000
CY2011Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1374000
CY2011Q4 us-gaap Assets
Assets
51805000
CY2011Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
3837000
CY2011Q4 us-gaap Defined Benefit Plan Assets For Plan Benefits Noncurrent
DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent
1043000
CY2011Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
50923000
CY2011Q4 us-gaap Inventory Net
InventoryNet
279000
CY2011Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2011Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
59189000
CY2011Q4 us-gaap Assets Current
AssetsCurrent
32491000
CY2011Q4 us-gaap Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent
PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
1700000
CY2011Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
6566000
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
27001000
CY2011Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
5032000
CY2011Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
51805000
CY2011Q4 us-gaap Stockholders Equity
StockholdersEquity
-26077000
CY2011Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
18271000
CY2011Q4 us-gaap Liabilities
Liabilities
77882000
CY2011Q1 us-gaap Gross Profit
GrossProfit
5222000
CY2011Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
242000
CY2011Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
256000
CY2011Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2650000
CY2011Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1654000
CY2011Q1 us-gaap Revenues
Revenues
4128000
CY2011Q1 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
1410000
CY2011Q1 us-gaap Reimbursement Revenue
ReimbursementRevenue
2292000
CY2011Q1 us-gaap Share Based Compensation
ShareBasedCompensation
242000
CY2011Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
2561000
CY2011Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
46000
CY2011Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
248000
CY2011Q1 us-gaap Net Income Loss
NetIncomeLoss
-5052000
CY2011Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10563000
CY2011Q1 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-64000
CY2011Q1 us-gaap Cost Of Revenue
CostOfRevenue
778000
CY2011Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
20590000
CY2011Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2604000
CY2011Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-5038000
CY2011Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-14000
CY2011Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
14327000
CY2011Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
29000
CY2011Q1 us-gaap Pension And Other Postretirement Benefit Expense
PensionAndOtherPostretirementBenefitExpense
33000
CY2011Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-88000
CY2011Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-1141000
CY2011Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1989000
CY2011Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
20936000
CY2011Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.06
CY2011Q1 plx Depreciation Amortization And Asset Impairment
DepreciationAmortizationAndAssetImpairment
878000
CY2011Q1 plx Supplemental Offering And Stock Issuance Costs
SupplementalOfferingAndStockIssuanceCosts
90000
CY2011Q1 plx Increase In Liabilities For Property Plant And Equipment
IncreaseInLiabilitiesForPropertyPlantAndEquipment
1194000
CY2011Q1 plx Research Development And Engineering Expense Net
ResearchDevelopmentAndEngineeringExpenseNet
8271000
CY2011Q1 plx Weighted Average Number Basic Diluted Shares Outstanding
WeightedAverageNumberBasicDilutedSharesOutstanding
81744547 shares
CY2011Q1 plx Other Gains Losses
OtherGainsLosses
1872000
CY2011Q1 plx Proceeds From Issuance Of Common Stock Net Of Expenses
ProceedsFromIssuanceOfCommonStockNetOfExpenses
20680000
CY2011Q1 plx Cashless Exercise Of Stock Options
CashlessExerciseOfStockOptions
1000
CY2012Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2012Q1 dei Trading Symbol
TradingSymbol
PLX
CY2012Q1 dei Entity Registrant Name
EntityRegistrantName
PROTALIX BIOTHERAPEUTICS, INC.
CY2012Q1 dei Amendment Flag
AmendmentFlag
false
CY2012Q1 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2012Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2012
CY2012Q1 dei Document Type
DocumentType
10-Q
CY2012Q1 dei Document Period End Date
DocumentPeriodEndDate
2012-03-31
CY2012Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001006281
CY2012Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2012Q1 us-gaap Gross Profit
GrossProfit
2408000
CY2012Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
129000
CY2012Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
36000
CY2012Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-852000
CY2012Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1270000
CY2012Q1 us-gaap Revenues
Revenues
3861000
CY2012Q1 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
1780000
CY2012Q1 us-gaap Pension And Other Postretirement Benefit Contributions
PensionAndOtherPostretirementBenefitContributions
5000
CY2012Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-6281000
CY2012Q1 us-gaap Reimbursement Revenue
ReimbursementRevenue
2003000
CY2012Q1 us-gaap Share Based Compensation
ShareBasedCompensation
129000
CY2012Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-242000
CY2012Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
42000
CY2012Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
7000
CY2012Q1 us-gaap Net Income Loss
NetIncomeLoss
-5904000
CY2012Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8847000
CY2012Q1 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
114000
CY2012Q1 us-gaap Cost Of Revenue
CostOfRevenue
1320000
CY2012Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
25388000
CY2012Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
810000
CY2012Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-6065000
CY2012Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
161000
CY2012Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
18604000
CY2012Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
163000
CY2012Q1 us-gaap Pension And Other Postretirement Benefit Expense
PensionAndOtherPostretirementBenefitExpense
44000
CY2012Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-16000
CY2012Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-2405000
CY2012Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1629000
CY2012Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
25574000
CY2012Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.07
CY2012Q1 plx Depreciation Amortization And Asset Impairment
DepreciationAmortizationAndAssetImpairment
930000
CY2012Q1 plx Supplemental Offering And Stock Issuance Costs
SupplementalOfferingAndStockIssuanceCosts
150000
CY2012Q1 plx Increase In Liabilities For Property Plant And Equipment
IncreaseInLiabilitiesForPropertyPlantAndEquipment
829000
CY2012Q1 plx Research Development And Engineering Expense Net
ResearchDevelopmentAndEngineeringExpenseNet
6844000
CY2012Q1 plx Weighted Average Number Basic Diluted Shares Outstanding
WeightedAverageNumberBasicDilutedSharesOutstanding
87821078 shares
CY2012Q1 plx Other Gains Losses
OtherGainsLosses
-133000
CY2012Q1 plx Proceeds From Issuance Of Common Stock Net Of Expenses
ProceedsFromIssuanceOfCommonStockNetOfExpenses
25538000
CY2012Q1 plx Cashless Exercise Of Stock Options
CashlessExerciseOfStockOptions
2000

Files In Submission

Name View Source Status
0001144204-12-027198-index-headers.html Edgar Link pending
0001144204-12-027198-index.html Edgar Link pending
0001144204-12-027198.txt Edgar Link pending
0001144204-12-027198-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
plx-20120331.xml Edgar Link completed
plx-20120331.xsd Edgar Link pending
plx-20120331_cal.xml Edgar Link unprocessable
plx-20120331_def.xml Edgar Link unprocessable
plx-20120331_lab.xml Edgar Link unprocessable
plx-20120331_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v311895_10q.htm Edgar Link pending
v311895_ex31-1.htm Edgar Link pending
v311895_ex31-2.htm Edgar Link pending
v311895_ex32-1.htm Edgar Link pending
v311895_ex32-2.htm Edgar Link pending